Endothelial Natriuretic Peptide Receptor 1 Play Crucial Role for Acute and Chronic Blood Pressure Regulation by Atrial Natriuretic Peptide
Takeshi TokudomeKentaro OtaniYuanjie MaoLars Jørn JensenYuji AraiTakahiro MiyazakiTakashi SonobeJames T. PearsonTsukasa OsakiNaoto MinaminoJunji IshidaAkiyoshi FukamizuHayato KawakamiDaisuke OnozukaKunihiro NishimuraMikiya MiyazatoHirohito NishimuraDepartment of Biochemistry,National Cerebral and Cardiovascular Center Research Institute,Osaka,Japan. (T.T.,Y.M.,N.M.,M.M.,H.N.)Department of Regenerative Medicine and Tissue Engineering,National Cerebral and Cardiovascular Center Research Institute,Osaka,Japan. (K.O.)Department of Research Promotion and Management,National Cerebral and Cardiovascular Center Research Institute,Osaka,Japan. (Y.A.)Department of Cell Biology,National Cerebral and Cardiovascular Center Research Institute,Osaka,Japan. (T.M.)Department of Cardiac Physiology,National Cerebral and Cardiovascular Center Research Institute,Osaka,Japan. (T.S.,J.T.P.)Department of Preventive Medicine and Epidemiology,National Cerebral and Cardiovascular Center Research Institute,Osaka,Japan. (K.N.)Department of Veterinary and Animal Sciences,Faculty of Health and Medical Sciences,University of Copenhagen,Denmark (L.J.J.).Department of Biochemistry and Molecular Biology,Yamagata University School of Medicine,Japan (T.O.).Life Science Center for Survival Dynamics,Tsukuba Advanced Research Alliance,University of Tsukuba,Ibaraki,Japan (J.I.,A.F.).Department of Anatomy,Kyorin University School of Medicine,Mitaka,Tokyo,Japan (H.K.).Department of Medical Informatics and Clinical Epidemiology,Graduate School of Medical Science,Kyoto Prefectural University of Medicine,Japan (D.O.).Diabetes Institute,Ohio University,Athens (Y.M.).Monash Biomedicine Discovery Institute and Department of Physiology,Monash University,Clayton,Australia (J.T.P.).
DOI: https://doi.org/10.1161/HYPERTENSIONAHA.121.18114
IF: 9.8968
2022-05-11
Hypertension
Abstract:ANP (atrial natriuretic peptide), acting through NPR1 (natriuretic peptide receptor 1), provokes hypotension. Such hypotension is thought to be due to ANP inducing vasodilation via NPR1 in the vasculature; however, the underlying mechanism remains unclear. Here, we investigated the mechanisms of acute and chronic blood pressure regulation by ANP. Immunohistochemical analysis of rat tissues revealed that NPR1 was abundantly expressed in endothelial cells and smooth muscle cells of small arteries and arterioles. Intravenous infusion of ANP significantly lowered systolic blood pressure in wild-type mice. ANP also significantly lowered systolic blood pressure in smooth muscle cell–specific Npr1 –knockout mice but not in endothelial cell–specific Npr1 –knockout mice. Moreover, ANP significantly lowered systolic blood pressure in Nos3 -knockout mice. In human umbilical vein endothelial cells, treatment with ANP did not influence nitric oxide production or intracellular Ca 2+ concentration, but it did hyperpolarize the cells. ANP-induced hyperpolarization of human umbilical vein endothelial cells was inhibited by several potassium channel blockers and was also abolished under knockdown of RGS2 (regulator of G-protein signaling 2), an GTPase activating protein in G-protein α-subunit. ANP increased Rgs2 mRNA expression in human umbilical vein endothelial cells but failed to lower systolic blood pressure in Rgs2 -knockout mice. Endothelial cell–specific Npr1 -overexpressing mice exhibited lower blood pressure than did wild-type mice independent of RGS2, and showed dilation of arterial vessels on synchrotron radiation microangiography. Together, these results indicate that vascular endothelial NPR1 plays a crucial role in ANP-mediated blood pressure regulation, presumably by a mechanism that is RGS2-dependent in the acute phase and RGS2-independent in the chronic phase.
peripheral vascular disease